Topic
Chemotherapy
32 Podcasts • 6 Cases • 5 Courses on BackTable
Hear how experienced physicians approach Chemotherapy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 58 • 05 May 2026
Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options are available for second-line therapy? In this episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi explore the uncertain landscape of second-line treatment after first-line immunotherapy, such as atezolizumab and bevacizumab or the STRIDE regimen, including practical considerations for choosing which second-line therapy to use.
More on Chemotherapy
Loading recent podcasts…
Tumor Board Episode #58
May 5, 2026
with Dr. Craig Lockhart, Dr. Lingling Du
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
Tumor Board Episode #55
Apr 14, 2026
with Dr. Shruti Patel, Dr. Jun Gong
How will the newest colorectal cancer trial results discussed at the 2026 ASCO GI Cancers Symposium in San Francisco...
150+ listens
Tumor Board Episode #45
Jan 27, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
210+ listens
Tumor Board Episode #43
Jan 13, 2026
with Dr. Jun Gong, Dr. Jonathan Mizrahi
Get caught up on the cutting edge colorectal cancer trial data from ESMO 2025 with this 30-minute BackTable Tumor Board...
230+ listens
Tumor Board Episode #56
Apr 21, 2026
with Dr. Jessica Jones, Dr. Lindsay Peterson
Here’s a practical guide on how biomarkers can guide treatment and cut costs for your breast cancer patients. In this...
100+ listens
Tumor Board Episode #47
Feb 10, 2026
with Dr. Wade Iams, Dr. Kate Baker
Bispecific antibodies are emerging as an important therapeutic class in non-small cell lung cancer (NSCLC); but how do...
380+ listens
Tumor Board Episode #44
Jan 20, 2026
with Dr. Jonathan Mizrahi, Dr. Jun Gong
The FLOT regimen is the standard-of-care for upper gastroesophageal malignancies, but what if there were other drug...
120+ listens
Tumor Board Episode #42
Jan 6, 2026
with Dr. Rebecca Snyder, Dr. Jonathan Mizrahi
For the small subset of pancreatic cancer patients whose cancer is detected early and remains localized, there are now...
240+ listens
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
ENT Case
Oct 28, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Urology Course
3 hours, 28 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.